Got News to Share? Send 2 FREE Releases ↓
All News Topics | Events By Topic | By Country | By State | By Date

Cancer Immnuotherapy

Submit News
Date: 27-Feb-12 to 29-Feb-12
Location: Boston / United States
Category: Healthcare & Pharmaceuticals

Investigating the Development, Commercialization and Use of Immunotherapeutic Products
According to GLOBOCAN, over twelve billion people worldwide were believed to have cancer in 2008 and in the same year, cancer accounted for 7.5 million deaths worldwide. Furthermore, according to the American Cancer Society, 1 in 4 deaths in the US can be attributed to cancer. With such a staggering number of people affected by cancer, clinical development of therapies that may have a beneficial impact on outcomes is critical.

An estimated 130 potential cancer vaccine are now being studied, many in advanced clinical trials. This ship is setting sail and your company won’t want to be the last to jump on board.

What’s in it for you?
✓ Insight from top immunotherapy leaders spearheading the industry
✓ Thoughts from both early and late stage anticancer companies
✓ Up to 18 hours of training including interactive panel discussions
✓ Networking opportunities with industry leaders
✓ Exclusive online access to presentations for 3 months
✓ Opportunities to interact with leading experts and service providers
✓ Learning material to assist you in your crucial role moving forward

Visitors

Who will you meet at the conference?
Stakeholders from all aspects of Cancer Immunotherapy including C-level Executives, VPs, Directors, Heads, Scientists, and Research Leaders working in:
➤ Cellular Oncogenesis ➤ Tumor Immunology
➤ Immunotherapy ➤ Oncology
➤ Microbiology ➤ Cancer vaccines
➤ Big pharma

Exhibitors

CRO's, Technoloy Vendors, delivering technology, bioprocess technology, Cell Culture and Cell Line Development.

Go to event website